13F HOLDINGS REPORT
Catalio Capital Management, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001958125-25-000007
Total Value
$476.9M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 53,916 | $42.0M | 8.81% |
| 2 | BRIDGEBIO PHARMA INC | BBIO | 927,711 | $40.1M | 8.40% |
| 3 | SOLENO THERAPEUTICS INC | SLNO | 409,944 | $34.3M | 7.20% |
| 4 | ASCENDIS PHARMA A/S | ASND | 179,926 | $31.1M | 6.51% |
| 5 | INTUITIVE SURGICAL INC | ISRG | 56,674 | $30.8M | 6.46% |
| 6 | EDWARDS LIFESCIENCES CORP | EW | 390,932 | $30.6M | 6.41% |
| 7 | GILEAD SCIENCES INC | GILD | 226,875 | $25.2M | 5.27% |
| 8 | BOSTON SCIENTIFIC CORP | BSX | 229,046 | $24.6M | 5.16% |
| 9 | CYTOKINETICS INC | CYTK | 601,439 | $19.9M | 4.17% |
| 10 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,104,512 | $19.7M | 4.13% |
| 11 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,170,372 | $19.6M | 4.11% |
| 12 | CORCEPT THERAPEUTICS INC | CORT | 239,125 | $17.6M | 3.68% |
| 13 | NATERA INC | NTRA | 97,297 | $16.4M | 3.45% |
| 14 | ADAPTIVE BIOTECHNOLOGIES COR | ADTI | 1,396,445 | $16.3M | 3.41% |
| 15 | DIANTHUS THERAPEUTICS INC | DNTH | 746,527 | $13.9M | 2.92% |
| 16 | STRUCTURE THERAPEUTICS INC | GPCR | 670,575 | $13.9M | 2.92% |
| 17 | ADMA BIOLOGICS INC | ADMA | 569,704 | $10.4M | 2.18% |
| 18 | HALOZYME THERAPEUTICS INC | HALO | 191,529 | $10.0M | 2.09% |
| 19 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 213,402 | $7.8M | 1.63% |
| 20 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 162,596 | $7.7M | 1.61% |
| 21 | PHATHOM PHARMACEUTICALS INC | PHAT | 672,290 | $6.4M | 1.35% |
| 22 | UNIQURE NV | QURE | 417,443 | $5.8M | 1.22% |
| 23 | GENEDX HOLDINGS CORP | WGSWW | 61,507 | $5.7M | 1.19% |
| 24 | PROTARA THERAPEUTICS INC | TARA | 1,626,370 | $4.9M | 1.03% |
| 25 | OUTSET MED INC | OM | 166,666 | $3.2M | 0.67% |
| 26 | SEPTERNA INC | SEPN | 294,360 | $3.1M | 0.65% |
| 27 | REPLIMUNE GROUP INC | REPL | 330,337 | $3.1M | 0.64% |
| 28 | ZENAS BIOPHARMA INC | ZBIO | 215,314 | $2.1M | 0.44% |
| 29 | VIR BIOTECHNOLOGY INC | VIR | 388,303 | $2.0M | 0.41% |
| 30 | KYVERNA THERAPEUTICS INC | KYTX | 586,909 | $1.8M | 0.38% |
| 31 | DISC MEDICINE INC | IRON | 30,661 | $1.6M | 0.34% |
| 32 | FULCRUM THERAPEUTICS INC | FULC | 188,304 | $1.3M | 0.27% |
| 33 | BICARA THERAPEUTICS INC | BCAX | 97,800 | $908,562 | 0.19% |
| 34 | METAGENOMI INC | MGX | 528,993 | $782,910 | 0.16% |
| 35 | KARYOPHARM THERAPEUTICS INC | KPTI | 146,013 | $629,316 | 0.13% |
| 36 | HYPERFINE INC | HYPR | 760,035 | $546,921 | 0.11% |
| 37 | MERSANA THERAPEUTICS INC | 59045L106 | 1,567,413 | $463,954 | 0.10% |
| 38 | ATAI LIFE SCIENCES NV | N0731H103 | 196,858 | $431,119 | 0.09% |
| 39 | FRACTYL HEALTH INC | GUTS | 214,236 | $347,062 | 0.07% |
| 40 | SENSEI BIOTHERAPEUTICS INC | SNSE | 14,718 | $126,280 | 0.03% |